ACTIVE

PHAROMED

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

28,3 k €

+103.2% YoY

Gross margin

47,8 k €

+48.7% YoY

Equity

39,2 k €

+9.2% YoY

What does PHAROMED do?

PHAROMED is a Private limited company incorporated in 2011. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Blégny.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0839.991.789

Incorporation

06/10/2011

Legal form

Private limited company

Registered office

Rue des Mésanges 3
4671 Blégny · WallonieSee on map

Contributed capital

6 386,00 €

Latest accounts

31/12/2025

Activities (NACE)

82990Other business support service activities n.e.c.· main 82990Other business support service activities n.e.c.

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012
Income statement
Gross margin	47,8 k €	+48.7%	32,1 k €	+57.0%	20,5 k €	-31.2%	29,8 k €	+92.6%	15,5 k €	+862%	-2 k €	+12.2%	-2,3 k €	-107%	32,1 k €	+57.4%	20,4 k €	+70.7%	11,9 k €	-49.2%	23,5 k €	+17.9%	19,9 k €	-38.1%	32,2 k €	+9.7%	29,4 k €
EBITDA	46,4 k €	+76.4%	26,3 k €	+66.0%	15,9 k €	-35.8%	24,7 k €	+197%	8,3 k €	+261%	-5,2 k €	+2.9%	-5,3 k €	-118%	30,4 k €	+641%	4,1 k €	-63.0%	11,1 k €	-52.4%	23,3 k €	+18.9%	19,6 k €	-38.4%	31,8 k €	+9.1%	29,2 k €
Operating result	44,6 k €	+82.4%	24,4 k €	+63.9%	14,9 k €	-38.1%	24,1 k €	+212%	7,7 k €	+220%	-6,4 k €	-7.5%	-6 k €	-120%	29,8 k €	+815%	3,3 k €	+24.1%	2,6 k €	-82.1%	14,7 k €	+35.4%	10,9 k €	-52.5%	22,9 k €	-19.0%	28,2 k €
Net result	28,3 k €	+103%	13,9 k €	+41.2%	9,9 k €	-14.0%	11,5 k €	+148%	4,6 k €	+160%	-7,7 k €	-27.2%	-6 k €	-126%	23,1 k €	+1158%	1,8 k €	+15.8%	1,6 k €	+215%	-1,4 k €	-113%	10,7 k €	-36.0%	16,8 k €	-7.6%	18,2 k €
Balance sheet
Equity	39,2 k €	+9.2%	36 k €	+63.2%	22 k €	+3.5%	21,3 k €	+117%	9,8 k €	+88.9%	5,2 k €	-59.6%	12,9 k €	-31.9%	18,9 k €	+80.9%	10,4 k €	+16.1%	9 k €	+15.4%	7,8 k €	-75.9%	32,4 k €	+4.0%	31,2 k €	+117%	14,4 k €
Total assets	198,2 k €	+17.9%	168 k €	+50.2%	111,9 k €	-11.5%	126,4 k €	+4.0%	121,6 k €	+16.2%	104,7 k €	-10.6%	117,1 k €	+52.0%	77,1 k €	+79.8%	42,9 k €	+55.4%	27,6 k €	-27.7%	38,1 k €	-39.1%	62,7 k €	+18.8%	52,8 k €	+16.5%	45,3 k €
Cash	1,4 k €	-74.9%	5,4 k €	+226%	1,7 k €	-89.2%	15,3 k €	+2062%	706,7 €	-84.6%	4,6 k €	+59533%	7,7 €	-99.9%	9,5 k €	-14.3%	11 k €	+392%	2,2 k €	-3.9%	2,3 k €	+23.3%	1,9 k €	-61.9%	5 k €	-79.2%	23,8 k €
Debts	157,1 k €	+19.0%	132 k €	+47.4%	89,6 k €	-14.8%	105,1 k €	-5.9%	111,8 k €	+12.4%	99,5 k €	-2.9%	102,5 k €	+81.7%	56,4 k €	+75.3%	32,2 k €	+99.2%	16,2 k €	-43.8%	28,7 k €	+2.0%	28,2 k €	+63.8%	17,2 k €	-40.4%	28,9 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Mehdi BEN BRAHIM

Director

Active

Ended mandates

Mehdi BEN BRAHIM

Manager · since 30 septembre 2011

Ended

Robin CRUNENBERG

Manager · since 30 septembre 2011

Ended

Mehdi BEN BRAHIM

Administrator - manager

Ended

Mehdi BEN BRAHIM

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/08/2026	30/04/2025	14/06/2024	31/08/2023	29/08/2022	27/08/2021
General meeting	30/06/2026	10/04/2025	03/05/2024	30/06/2023	31/07/2022	31/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

14 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	30/06/2026	20/08/2026	French	PDF
Micro model	31/12/2024	10/04/2025	30/04/2025	French	PDF
Micro model	31/12/2023	03/05/2024	14/06/2024	French	PDF
Micro model	31/12/2022	30/06/2023	31/08/2023	French	PDF
Micro model	31/12/2021	31/07/2022	29/08/2022	French	PDF
Micro model	31/12/2020	31/07/2021	27/08/2021	French	PDF
Micro model	31/12/2019	31/07/2020	02/10/2020	French	PDF
Micro model	31/12/2018	30/07/2019	31/07/2019	French	PDF
Micro model	31/12/2017	07/03/2018	04/04/2018	French	PDF
Micro model	31/12/2016	30/06/2017	13/07/2017	French	PDF
Abridged model	31/12/2015	24/08/2016	26/08/2016	French	PDF
Abridged model	31/12/2014	26/08/2015	28/08/2015	French	PDF
Abridged model	31/12/2013	14/07/2014	29/07/2014	French	PDF
Abridged model	31/12/2012	20/02/2013	11/04/2013	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Mehdi BEN BRAHIM

Director

Active

Ended mandates

Mehdi BEN BRAHIM

Manager · since 30 septembre 2011

Ended

Robin CRUNENBERG

Manager · since 30 septembre 2011

Ended

Mehdi BEN BRAHIM

Administrator - manager

Ended

Mehdi BEN BRAHIM

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/11/2023
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Registered office23/01/2019
SIEGE SOCIAL
PDF
Mandates24/04/2018
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Mandates25/11/2015
DEMISSIONS, NOMINATIONS
PDF
Other18/10/2011
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202528,3 k €↑
2024
Annual accounts 202413,9 k €↑
2023
Annual accounts 20239,9 k €↓
2022
Annual accounts 202211,5 k €↑
2021
Annual accounts 20214,6 k €↑
2020
Annual accounts 2020-7,7 k €↓
2019
Annual accounts 2019-6 k €↓
2018
Annual accounts 201823,1 k €↑
2017
Annual accounts 20171,8 k €↑
2016
Annual accounts 20161,6 k €↑
2015
Annual accounts 2015-1,4 k €↓
2014
Annual accounts 201410,7 k €↓
2013
Annual accounts 201316,8 k €↓
2012
Annual accounts 201218,2 k €
06/10/2011
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHAROMED

Overview

What does PHAROMED do?

Trend over 14 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline